Image

Study of Acupoints in Diminished Ovarian Reserve Based on Biological Characteristics

Study of Acupoints in Diminished Ovarian Reserve Based on Biological Characteristics

Recruiting
18-39 years
Female
Phase N/A

Powered by AI

Overview

Diminished Ovarian Reserve (DOR) is characterized by decreased female fertility, menstrual disorders and perimenopausal symptoms due to sex hormone deficiency or fluctuations. For now, there are no uniform diagnostic criteria or an ideal single detection index for DOR because of its insidious etiology and pathogenesis,theories suggest that there are specific changes in the body surface or acupuncture points in a pathological state. By detecting the biological characteristics of relevant meridian points and exploring the specificity and regularity of it.

Description

There will be a multi-center, case-control, observational experiment. 50 patients with DOR and 50 healthy participants will be involved from Third Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medicine University and social recruitment. Modern instruments are used to regularly test the pain threshold, infrared thermal image, resistance, micro-circulation, and biological ultra-weak luminescence. There will be no randomized methods and blindness for subjects, while assessors and statisticians are masked from patients or healthy people. The study is aim to explore the the relevance between meridian acupoints and DOR.

Eligibility

Inclusion Criteria:

Inclusion criteria for patient with DOR:

  • 18 years old ≤ age < 40 years old, female;
  • Clinical diagnosis of Diminished Ovarian Reserve: meet both items in twice tests with an interval of at least 4 weeks(tested between 2rd to 4th day of menstrual cycle):
    1. 10 IU/L < FSH < 20 IU/L,
    2. Anti-Müllerian hormone(AMH) < 1.1ng/mL.
  • without any mind disease, willing to participate in the study and sign the informed

    consent.

  • without any other treatment.

Inclusion criteria for healthy participants:

  • healthy participants who can provide medical examination reports within the past 1 year and have routine physical examination conducted by researchers to confirm that there are no serious underlying diseases of the reproductive system, urinary system, blood, endocrine, nervous system, etc.;
  • without symptoms of oligomenorrhea or amenorrhea at present;
  • between the ages of 18 to 40, female;
  • without any mind disease, volunteering to participate in the study and sign the informed consent.

Exclusion Criteria:

Exclusion Criteria for patient with DOR

  • Low or no response to exogenous gonadotropins, or with congenital anomalies in the development of the reproductive tract;
  • Pregnant or breastfeeding;
  • Abnormal body temperatures at the moment;
  • Psychopath, alcoholic, Patient with severe depression, history of substance abuse and severe primary diseases of cardiovascular, liver, kidney and hematopoietic system;
  • Currently enrolled in other clinical trials or refuse to cooperate with the study protocol.

Exclusion Criteria for healthy participants

  • Patient with mental illness, severe depression, alcohol dependence or a history of drug abuse;
  • In pregnant or breastfeeding;
  • abnormal body temperature at present;
  • Participants who are currently participating in other clinical trials or who do not cooperate with the study protocol.

Study details
    Diminished Ovarian Reserve

NCT06395623

Xiaomei Shao

16 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.